...
首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management
【24h】

Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management

机译:异位妊娠:使用hCG比率选择孕妇进行预期或药物治疗

获取原文
获取原文并翻译 | 示例

摘要

Objective. To identify variables that can be used to select women with an ectopic pregnancy for expectant or medical management with systemic methotrexate. Design. Cohort study. Setting. Early Pregnancy Unit of a London teaching hospital. Population. Women with a tubal ectopic pregnancy managed non-surgically. Methods. The diagnosis of tubal ectopic pregnancy was made using transvaginal sonog-raphy. Human chorionic gonadotrophin (hCG) levels had to be taken at 0 hour and 48 hours pre-treatment. Other recorded variables include presenting complaints, gestational age, progesterone levels, size of the ectopic mass and appearance of the ectopic on transvaginal sonography. Women were followed up until the outcome (success or failure) of management was known. Main outcome measures. Univariable analysis was performed to identify the variables associated with successful management using area under curves and relative risks. Results. Thirty-nine women underwent expectant management (overall success rate 71.8%) and 42 had medical management (overall success rate 76.2%). The pre-treatment hCG ratio (hCG 48 hours/hCG 0 hour) was related to the failure of both expectant (area under curve 0.86, 95% CI 0.67-0.94) and medical (area under curve 0.79, 95% CI 0.58-0.90) management. History of ectopic pregnancy was related to failure of expectant management only (relative risk 0.46, 95% CI 0.16-0.92). Conclusions. The most important variable for predicting the likelihood of successful non-surgical management was the pre-treatment hCG ratio. New studies are required to validate the use of this variable and of history of ectopic pregnancy to predict the likelihood of successful non-surgical management in clinical practice.
机译:目的。找出可用于选择异位妊娠妇女进行系统氨甲蝶呤的预期或药物治疗的变量。设计。队列研究。设置。伦敦教学医院的早孕部门。人口。输卵管异位妊娠的妇女非手术治疗。方法。输卵管异位妊娠的诊断采用经阴道超声检查。人绒毛膜促性腺激素(hCG)水平必须在治疗前0小时和48小时服用。其他记录的变量包括提出的主诉,胎龄,孕酮水平,异位肿块的大小和经阴道超声检查中异位的外观。对妇女进行随访,直到知道治疗的结果(成功或失败)为止。主要观察指标。进行单变量分析以使用曲线下的面积和相对风险来确定与成功管理相关的变量。结果。三十九名妇女接受了预期管理(总成功率为71.8%),有42名接受了医疗管理(总成功率为76.2%)。治疗前的hCG比率(hCG 48小时/ hCG 0小时)与预期(曲线下面积0.86,95%CI 0.67-0.94)和医疗(曲线下面积0.79,95%CI 0.58-0.90)的失败有关)管理。异位妊娠史仅与预期治疗失败有关(相对危险度0.46,95%CI 0.16-0.92)。结论预测成功非手术治疗的可能性的最重要变量是治疗前的hCG比率。需要进行新的研究以验证该变量的使用和异位妊娠的历史,以预测临床实践中成功进行非手术治疗的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号